Tech Company Financing Transactions
Xilio Therapeutics Funding Round
Xilio Therapeutics closed a $30 million Series A funding round on 9/28/2018. Investors included Atlas Venture, F-Prime Capital and private investors.
Atlas Venture (Lead Investor) (David Grayzel)
F-Prime Capital (Lead Investor) (Benjamin Auspitz)
Waltham, MA 02451
Browse more venture capital transactions:
Prev: 9/28/2018: AbCellera venture capital transaction
Next: 9/28/2018: Broadly venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs